Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇应助刚国忠采纳,获得10
刚刚
mylove应助Sid采纳,获得10
1秒前
承乐发布了新的文献求助30
1秒前
1秒前
2秒前
2秒前
量子星尘发布了新的文献求助10
2秒前
王宽宽宽完成签到,获得积分10
3秒前
3秒前
科研通AI6应助13nnk采纳,获得10
4秒前
程昌盛完成签到,获得积分10
4秒前
Aprilapple发布了新的文献求助10
4秒前
5秒前
华仔应助一十六采纳,获得10
5秒前
5秒前
完美世界应助王彦林采纳,获得10
5秒前
去玩儿完成签到,获得积分20
6秒前
6秒前
王宽宽宽发布了新的文献求助10
6秒前
lwq发布了新的文献求助10
6秒前
Grace完成签到,获得积分10
7秒前
华仔应助YaHaa采纳,获得10
8秒前
滕可燕发布了新的文献求助10
8秒前
爆米花应助陈甜甜采纳,获得10
9秒前
摆烂小鱼鱼完成签到 ,获得积分10
9秒前
Lucas应助韩麒嘉采纳,获得10
9秒前
9秒前
9秒前
10秒前
Niuniu完成签到,获得积分10
10秒前
裴裴驳回了珏晴应助
10秒前
11秒前
11秒前
11秒前
11秒前
Aprilapple完成签到,获得积分10
11秒前
12秒前
song发布了新的文献求助10
12秒前
兴奋的发卡完成签到 ,获得积分10
13秒前
自觉翠安应助qiuxiali123采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
人脑智能与人工智能 1000
花の香りの秘密―遺伝子情報から機能性まで 800
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
Pharmacology for Chemists: Drug Discovery in Context 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5608504
求助须知:如何正确求助?哪些是违规求助? 4693127
关于积分的说明 14876947
捐赠科研通 4717761
什么是DOI,文献DOI怎么找? 2544250
邀请新用户注册赠送积分活动 1509316
关于科研通互助平台的介绍 1472836